New York, NY May 23, 2012 — The final rules on how the Physician Payment Sunshine Act will be implemented are due to be released this summer and the pressure is bearing down on pharmaceutical and medical device companies with hefty 'failure to comply' fines up to $1 million. It's imperative that the life science industry starts to prepare now on how to address physician inquires and disputes on the data that will be published in an online, searchable database for the public to review in 2013.
To help industry executives prepare for the new January 1, 2013 Sunshine Act compliance deadline, MMIS, Inc. presented an FDAnews webinar and answered questions from executives during the 90-minute session. Participants got an in-depth look at the proposed rules, learning about best practices currently employed by MMIS clients and were presented with options to proactively share data with their customers to ensure accurate data reporting to the government while strengthening the customer – vendor relationship.
Michaeline Daboul, President and CEO of MMIS, Inc., and Tim Robinson, Esq., the Executive Vice President and General Counsel for MMIS, Inc. were the instructors and provided case study examples on how medical device and pharmaceutical companies have integrated both aggregate spend and HCP notification and dispute resolution processes into their current enterprise systems.
“Even though CMS has delayed the collection of data to begin January 1, 2013, large to mid-size life science companies have continued to source and implement aggregate spend tracking and reporting systems into their current enterprise platforms.” said Michaeline Daboul. “But the problem doesn’t end once you have implemented tracking and reporting system.”
The FDAnews webinar provided first hand insight into the problem every company will face, “How do you keep strengthening customer relationships during this new age of transparency? How will you proactively engage the customer in this process?”
The session covered real world knowledge transfer by providing case studies from companies with first-hand reporting experience and those who are running pilot programs for notification and dispute resolution.
For additional information on this webinar, visit FDAnews.com.
About MMIS, Inc.
MMIS, Inc. is a global technology company that develops secure communication solutions for many Fortune 500 companies. For over a decade, MMIS has deployed proprietary open collaboration technologies that enable its clients to drive greater productivity by managing and exchanging data, ideas, opinions, and intellectual capital in an ultra-secure environment.
Developed and marketed by MMIS, MediSpend® Family of Products are secure hosted platforms sold as a software-as-a-service (SaaS) solutions to meet the needs of industry, academic institutions and physicians. Developed by attorneys and IT specialists with over 13 years experience in healthcare compliance, the MediSpend® Family of Products represent the first end-to-end compliance solutions designed specifically to help pharmaceutical and medical device companies track and report HCP and HCO spend while simultaneously managing physician relationships. MediSpend® is a customizable, comprehensive, web-based solution that simplifies compliance with the Patient Protection Affordable Care Act.
For more information please visit medispend0.wpengine.com or contact us at email@example.com. MediSpend® is developed by MMIS, Inc., a global technology company with offices in New York, NY and Portsmouth, NH.
Tel: +1 (888) 731-7322 x8121
Fax: +1 (603) 926-3942